Inventor · disambiguated record
Masaki Seto
Also filed as: SETO MASAKI
26 granted patents·15 pending applications·196 citations·filing 1999–2025
95Inventor score
Files withTAKEDA PHARMACEUTICALS CO20TAKEDA PHARMACEUTICAL7SHIRAISHI MITSURU4TOBIRA THERAPEUTICS INC4SOLENT THERAPEUTICS LLC2
Top patents by PatentIndex Score
41 records- 0195US6627651B1Cyclic compounds and uses thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 2000·Granted Sep 30, 2003·61 cites·35 claims
- 0294US7507740B2Fused heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2005·Granted Mar 24, 2009·33 cites·2 claims
- 0391US11236099B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 1, 2022·4 cites·22 claims
- 0490US10980825B2Cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 20, 2021·6 cites·20 claims
- 0589US11666594B2Antibody-drug conjugates comprising a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 6, 2023·2 cites·19 claims
- 0689US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0787US8183273B2Bicyclic compound, production and use thereofSHIRAISHI MITSURU·Filed 2007·Granted May 22, 2012·10 cites·37 claims
- 0885US11560372B2Heterocyclic compounds useful as modulators of acetylcholine receptorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jan 24, 2023·2 cites·4 claims
- 0985US6235771B1Anilide derivative, production and use thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1999·Granted May 22, 2001·36 cites·33 claims
- 1084US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 1184US8362058B2Bicyclic compound, production and use thereofTOBIRA THERAPEUTICS INC·Filed 2008·Granted Jan 29, 2013·5 cites·13 claims
- 1283US8741943B2Bicyclic compound, production and use thereofSHIRAISHI MITSURU·Filed 2012·Granted Jun 3, 2014·5 cites·2 claims
- 1382US2025205270A1Antibody-drug conjugate precursors comprising a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1481US7371772B2Bicyclic compound, production and use thereofTAKEDA PHARMACEUTICAL·Filed 2002·Granted May 13, 2008·9 cites·1 claims
- 1580US12171777B2Methods of making a cyclic dinucleotideTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Dec 24, 2024·0 cites·20 claims
- 1679US9637483B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted May 2, 2017·4 cites·6 claims
- 1779US9085578B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jul 21, 2015·6 cites·8 claims
- 1876US7262185B2Benzazepine derivative, process for producing the same, and useTAKEDA PHARMACEUTICAL·Filed 2002·Granted Aug 28, 2007·6 cites·17 claims
- 1973US12024505B2Heterocyclic compounds useful as modulators of acetylcholine receptorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jul 2, 2024·0 cites·12 claims
- 2072US8178543B2Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitorsISHIKAWA TOMOYASU·Filed 2008·Granted May 15, 2012·1 cites·2 claims
- 2170US2020297700A1Bicyclic compound, production and use thereofTOBIRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2266US12378256B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 2365US10045968B2Bicyclic compound, production and use thereofTOBIRA THERAPEUTICS INC·Filed 2014·Granted Aug 14, 2018·0 cites·5 claims
- 2465US2019038604A1Bicyclic compound, production and use thereofTOBIRA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2563US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 2662US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2761US11970483B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 30, 2024·0 cites·16 claims
- 2860US12162864B2Condensed-cyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
- 2952US2025289792A13-amino-4h-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of mrgx2SOLENT THERAPEUTICS LLC·Filed 2025·Application pending·0 cites
- 3050US12247015B23-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2SOLENT THERAPEUTICS LLC·Filed 2020·Granted Mar 11, 2025·0 cites·22 claims
- 3149US2022289679A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 3249US2022023207A1Drug delivery system using solutionUNIV KYOTO·Filed 2019·Application pending·0 cites
- 3347US2010234351A1Fused nitrogen-comprising heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2007·Application pending·0 cites
- 3446US10131653B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Nov 20, 2018·0 cites·12 claims
- 3545US2017174682A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 3644US2010216788A1Fused heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2006·Application pending·0 cites
- 3744US2006178359A1Tricyclic compound, process for producing the same, and useSHIRAISHI MITSURU·Filed 2004·Application pending·0 cites
- 3844US2016159808A1Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 3944US2016264536A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Application pending·0 cites
- 4044US2006160864A1Acrylamide derivative, process for producing the same, and useSHIRAISHI MITSURU·Filed 2004·Application pending·0 cites
- 4142US11459325B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 4, 2022·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Masaki Seto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →